Kod miševa CRF1 receptori posreduju etanolno pojačanje GABAergične sinaptičke transmisije.[5]
Klinički značaj
Varijacije CRHR1 gena su povezane za povećanjem odgovora na inhalacionu kortikosteroidnu terapiju kod astme.[6] Antagonisti CRF1 receptora se aktivno ispituju kao mogući tretman za depresiju i anksioznost.[7][8]
↑Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (March 2003). „International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands”. Pharmacol. Rev.55 (1): 21–6. DOI:10.1124/pr.55.1.3. PMID12615952.
↑Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (July 1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22”. Genomics28 (1): 123–4. DOI:10.1006/geno.1995.1118. PMID7590738.
↑Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (March 2004). „Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors”. Science (journal)303 (5663): 1512–4. DOI:10.1126/science.1092550. PMID15001778.
↑Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, Liggett SB, Gelfand EW, Rosenwasser LJ, Richter B, Israel E, Wechsler M, Gabriel S, Altshuler D, Lander E, Drazen J, Weiss ST (July 2004). „Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids”. Hum. Mol. Genet.13 (13): 1353–9. DOI:10.1093/hmg/ddh149. PMID15128701.
↑Kehne JH (June 2007). „The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders”. CNS Neurol Disord Drug Targets6 (3): 163–82. DOI:10.2174/187152707780619344. PMID17511614.
↑Ising M, Holsboer F (December 2007). „CRH-sub-1 receptor antagonists for the treatment of depression and anxiety”. Exp Clin Psychopharmacol15 (6): 519–28. DOI:10.1037/1064-1297.15.6.519. PMID18179304.
↑Grammatopoulos, D K; Dai Y, Randeva H S, Levine M A, Karteris E, Easton A J, Hillhouse E W (December 1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. (UNITED STATES) 13 (12): 2189–202. DOI:10.1210/me.13.12.2189. ISSN0888-8809. PMID10598591.
↑Donaldson, C J; Sutton S W, Perrin M H, Corrigan A Z, Lewis K A, Rivier J E, Vaughan J M, Vale W W (May 1996). „Cloning and characterization of human urocortin”. Endocrinology (UNITED STATES) 137 (5): 2167–70. DOI:10.1210/en.137.5.2167. ISSN0013-7227. PMID8612563.
McLean M, Bisits A, Davies J, et al. (1995). „A placental clock controlling the length of human pregnancy.”. Nat. Med.1 (5): 460–3. DOI:10.1038/nm0595-460. PMID7585095.
Polymeropoulos MH, Torres R, Yanovski JA, et al. (1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22.”. Genomics28 (1): 123–4. DOI:10.1006/geno.1995.1118. PMID7590738.
Ross PC, Kostas CM, Ramabhadran TV (1995). „A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.”. Biochem. Biophys. Res. Commun.205 (3): 1836–42. DOI:10.1006/bbrc.1994.2884. PMID7811272.
Opdenakker G, Fiten P, Nys G, et al. (1994). „The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12.”. Genomics21 (2): 403–8. DOI:10.1006/geno.1994.1283. PMID7916328.
Vita N, Laurent P, Lefort S, et al. (1993). „Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.”. FEBS Lett.335 (1): 1–5. DOI:10.1016/0014-5793(93)80427-V. PMID8243652.
Donaldson CJ, Sutton SW, Perrin MH, et al. (1996). „Cloning and characterization of human urocortin.”. Endocrinology137 (5): 2167–70. DOI:10.1210/en.137.5.2167. PMID8612563.
Liaw CW, Grigoriadis DE, Lovenberg TW, et al. (1997). „Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach.”. Mol. Endocrinol.11 (7): 980–5. DOI:10.1210/me.11.7.980. PMID9178757.
Asakura H, Zwain IH, Yen SS (1997). „Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary.”. J. Clin. Endocrinol. Metab.82 (8): 2720–5. DOI:10.1210/jc.82.8.2720. PMID9253360.
Gottowik J, Goetschy V, Henriot S, et al. (1998). „Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.”. Neuropharmacology36 (10): 1439–46. DOI:10.1016/S0028-3908(97)00098-1. PMID9423932.
Grammatopoulos D, Dai Y, Chen J, et al. (1998). „Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria.”. J. Clin. Endocrinol. Metab.83 (7): 2539–44. DOI:10.1210/jc.83.7.2539. PMID9661640.
Sakai K, Yamada M, Horiba N, et al. (1998). „The genomic organization of the human corticotropin-releasing factor type-1 receptor.”. Gene219 (1-2): 125–30. DOI:10.1016/S0378-1119(98)00322-9. PMID9757017.
Grammatopoulos DK, Dai Y, Randeva HS, et al. (2000). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.”. Mol. Endocrinol.13 (12): 2189–202. DOI:10.1210/me.13.12.2189. PMID10598591.
Perrin MH, Fischer WH, Kunitake KS, et al. (2001). „Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor.”. J. Biol. Chem.276 (34): 31528–34. DOI:10.1074/jbc.M101838200. PMID11425856.
Pisarchik A, Slominski AT (2002). „Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression.”. FASEB J.15 (14): 2754–6. DOI:10.1096/fj.01-0487fje. PMID11606483.
Graziani G, Tentori L, Portarena I, et al. (2002). „CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.”. Endocrinology143 (3): 807–13. DOI:10.1210/en.143.3.807. PMID11861501.
King JS, Bishop GA (2003). „The distribution and cellular localization of CRF-R1 in the vermis of the postnatal mouse cerebellum.”. Exp. Neurol.178 (2): 175–85. DOI:10.1006/exnr.2002.8052. PMID12504877.